Rh Immunoprophylaxis and Fetal RHD Genotyping: Where are We Going?

Obstetrics and Gynecology

Volumn 120, Issue 2, 2012, Pages 219-220

  Queenan, John T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RHESUS D ANTIBODY;

AMNIOCENTESIS; BLOOD GROUP RHESUS SYSTEM; CELL FREE SYSTEM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG COST; EDITORIAL; GENE; GENOTYPE; HUMAN; IMMUNOPROPHYLAXIS; PERINATAL MORTALITY; PRIORITY JOURNAL; RHD GENE; RHESUS IMMUNIZATION; RHESUS ISOIMMUNIZATION;

BLOOD GROUP INCOMPATIBILITY; FEMALE; HUMANS; PREGNANCY; RH-HR BLOOD-GROUP SYSTEM;

EID: 84864247102     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182611bcb     Document Type: Editorial

References (9)

1. Freda VJ, Gorman JG, Pollack W. Successful prevention of experimental Rh sensitization in man with an anti-Rh gamma2-globulin antibody preparation: a preliminary report. Transfusion 1964;4:26-32.
2. Clarke CA, Donohue WT, McConnell RB, Woodrow JC, Finn R, Krevans JR, et al. Further experimental studies in the prevention of Rh haemolytic disease. Br Med J 1963;1:979-84.
3. Bowman JM, Chown B, Lewis M, Pollack JM. Rh isoimmunization during pregnancy: antenatal prophylaxis. Can Med Assoc J 1978;118:623-7.
4. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
5. Lo YM. Fetal RhD genotyping from maternal plasma. Ann Med 1999;31:308-12.
6. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high-throughput RHD typing in fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008;336:816-8.
7. Müller SP, Bartels I, Stein W, Emons G, Gutensohn K, Köhler M, et al. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 2008;48:2292-301.
8. Akolekar R, Finning K, Kuppusamy R, Daniels G, Nicolaides KH. Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation. Fetal Diagn Ther 2011;29:301-6.
9. Wikman AT, Tiblad E, Karlsson A, Olsson ML, Westgren M, Reilly M. Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol 2012;120:227-34.